← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: YILING · Approved 2019-09-30

Drug application

FDA Application #

ANDA210891

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

Pregabalin

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

YILING

First approval

2019-09-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown